4.3 Article

Fluorine in health care Organofluorine containing blockbuster drugs

期刊

JOURNAL OF FLUORINE CHEMISTRY
卷 131, 期 11, 页码 1071-1081

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.jfluchem.2010.03.003

关键词

Organofluorine drugs; Statins; Anti inflammatory; Antacids; Seritonin selective reuptake inhibitors; Neuroleptics; Antibiotics

向作者/读者索取更多资源

Organic fluorine compounds have had a profound impact on the development of bioactives for the modern pharmaceuticals market It is estimated that up to 20% of pharmaceuticals prescribed or administered in the clinic contain a fluorine atom and 30% of the leading 30 blockbuster drugs by sales contain a fluorine In this Highlight review the top 10 fluorine containing pharmaceuticals (by US Sales in 2008) are highlighted By this measure these are currently the most significant fluorinated compounds impacting on health care They embrace statins (Lipitor Crestor Vytorin Zetia/Ezetimibe) anti-inflammatories (fluticasone propionate Celebrex) antacid (Prevacid) antidepressants (Lexapro) neuroleptics (Risperdal) and antibiotics (Levaquin) In each case the structures and modes of action of these important drugs compounds are reviewed and representative synthetic routes are highlighted (C) 2010 Published by Elsevier BV

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据